PRF Technologies (PRFX) Cash from Financing Activities (2020 - 2023)
PRF Technologies (PRFX) recorded quarterly Cash from Financing Activities of $1.0 million in Q4 2023, down 71.56% on a QoQ basis from $3.6 million in Q3 2023.
PRF Technologies (PRFX) Cash from Financing Activities (2020 - 2023) Analysis & Trends
PRF Technologies has disclosed Cash from Financing Activities across 3 years of filings, most recently posting $1.0 million for Q4 2023.
- Quarterly Cash from Financing Activities changed N/A year-over-year to $1.0 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $6.5 million (changed N/A YoY) and the FY2025 annual result came in at $3.8 million, down 56.92% from the prior year.
- Cash from Financing Activities retreated to $1.0 million in Q4 2023, from $3.6 million in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $7.5 billion in Q3 2021 and troughed at -$7.5 billion in Q4 2021.
- A 3-year average of $4.9 million and a median of $4.6 million in 2021 frame the typical range for Cash from Financing Activities.
- Biggest YoY gain for Cash from Financing Activities was 42899.34% in 2021; the steepest drop was 42899.34% in 2021.
- Tracing PRFX's Cash from Financing Activities over 3 years: stood at $17.4 million in 2020, then slumped by 43088.25% to -$7.5 billion in 2021, then surged by 100.01% to $1.0 million in 2023.
- Business Quant data shows PRFX's Cash from Financing Activities at $1.0 million in Q4 2023, $3.6 million in Q3 2023, and -$7.5 billion in Q4 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 13.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -840.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -1.48 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -86.10 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -65.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.47 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -77.88 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -11.62 Mn |
| 10 | PRF Technologies | 933,081.16 | -2.46 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 1.02 Mn |
| Dec 31, 2023 | 1.02 Mn |
| Sep 30, 2023 | 3.59 Mn |
| Sep 30, 2023 | 3.59 Mn |
| Dec 31, 2021 | -7.48 Bn |
| Dec 31, 2021 | -7.48 Bn |
| Sep 30, 2021 | 7.48 Bn |
| Sep 30, 2021 | 7.48 Bn |
| Mar 31, 2021 | 5.55 Mn |
| Mar 31, 2021 | 5.55 Mn |
| Sep 30, 2020 | 17.39 Mn |
| Sep 30, 2020 | 17.39 Mn |